1
Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients
Condition(s):Central Nervous System Diseases; Central Nervous System NeoplasmsLast Updated:July 18, 2018Completed
MultiHance: 120 Clinical Trials, Page 1 of 12
Hide Studies Not Open or Pending
2
Gadolinium Retention in Human Bone Tissue in Pediatric Patients
Condition(s):Gadolinium; MultiHance; Dotarem; Magnetic Resonance Imaging; Gadolinium RetentionLast Updated:December 28, 2020Recruiting
3
Crossover Comparison of MultiHance and Dotarem
Condition(s):Brain DiseaseLast Updated:January 10, 2017Completed
4
Safety and Efficacy of MultiHance in Pediatric Patients
Condition(s):Central Nervous System DiseasesLast Updated:October 22, 2010Terminated
5
Multihance at 3 Tesla (3T) in Brain Tumors
Condition(s):Brain TumorLast Updated:November 5, 2020Completed
6
Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI.
Condition(s):Hepatocellular CarcinomaLast Updated:September 26, 2017Completed
7
Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration
Condition(s):Liver TumorLast Updated:January 13, 2017Completed
8
Study to Compare MultiHance With Gadovist in Magnetic Resonance Imaging (MRI) of the Brain
Condition(s):Brain LesionsLast Updated:January 5, 2012Completed
9
A Pharmacokinetics Study of MultiHance in Pediatric Patients
Condition(s):Central Nervous System PathologyLast Updated:January 11, 2008Completed
10
Evaluation of Gd Retention in Human Bone and Skin After MultiHance or ProHance Administration Compared With Control
Condition(s):Gadolinium RetentionLast Updated:August 14, 2020Completed